McKesson Corporation (MCK)

Mega-deals propel global M&A to record first half as companies pursue transformative acquisitionsJuly 3, 2026 10:34 AM
IH Market News Blockbuster transactions drive record deal values A wave of multibillion-dollar acquisitions pushed global mergers and acquisitions activity to unprecedented levels during the first half of 2026, as companies capitalised on a more favourable regulatory environment to pursue long-term strategic transactions. According to LSEG data, the total value of announced M&A deals reached $2.8 trillion during the first six months of the year, representing a 48% increase from the same period in 2025 and the highest year-to-date figure since records began in 1980. Despite the surge in value, overall deal volumes declined. Around 24,000 transactions were announced during the period, down 9% year over year and marking the lowest first-half total in six years. Mega-deals dominate global activity Large-scale transactions were the defining feature of the market. LSEG data showed 47 deals valued at more than $10 billion were announced during the first half, with a combined value exceeding $1.3 trillion. Those transactions accounted for almost half of all global M&A value, setting a new record for the proportion represented by mega-deals. Among the largest transactions were NextEra Energy’s (NYSE:NEE) $66.8 billion merger with Dominion Energy (NYSE:D) and SpaceX’s (NASDAQ:SPCX) acquisition of Cursor for approximately $60 billion. “Corporates have shown tremendous resilience in the face of geopolitical, monetary, macroeconomic, and even microeconomic volatility,” said Jay Hofmann, JPMorgan’s North America co-head of mergers and acquisitions. He added that financing “is available in size,” allowing companies to acquire strategic assets needed “to navigate change and put themselves in the best position for the future”. Boards increasingly favour transformational deals Investment bankers said corporate boards are becoming more willing to pursue ambitious acquisitions rather than smaller transactions. Ivan Farman, co-head of Global M&A at Bank of America, said stronger activity at the top end of the market reflects a growing belief that the effort required to execute a mid-sized acquisition is often comparable to completing a much larger deal. “Reflects a growing view that a $1 billion to $3 billion deal takes just as much time as a larger one, so when an opportunity for a big transaction arises, companies see this as the moment to act.” According to advisers, investors are increasingly rewarding companies with greater scale, stronger competitive positions and more focused business models. “Bigger companies that have bigger moats and a bigger competitive advantage are trading at much better multiples than smaller companies,” Farman said. “Long held aspirational or dream deals are now being actively rallied around, with CEOs and management teams pushing them forward to their boards.” Regulatory changes encourage dealmaking Many advisers believe M&A activity could eventually surpass the record levels seen following the pandemic in 2021, supported by a more accommodating regulatory backdrop. In Europe, policymakers have proposed reforms aimed at making it easier to create larger regional champions, while bankers believe the Trump administration has shown greater openness toward major US corporate combinations. Japan is also expected to contribute to higher deal activity as proposed revisions to corporate governance rules encourage companies to deploy excess cash more efficiently. “Momentum has actually started to accelerate behind the scenes over the last six weeks with a growing pipeline of cross-border, strategic deals,” said Jan Weber, Morgan Stanley’s head of mergers and acquisitions for Europe, the Middle East and Africa. “It feels like a lot of the indicators are on green for more M&A and boards feel that they need to act. I do think we are working towards the next peak,” Weber added. Ed Wittig, Goldman Sachs’ co-head of Asia Pacific mergers and acquisitions, said companies remain focused on expansion opportunities. “There’s strong enthusiasm around synergies, and markets are rewarding those that execute well,” he said. Corporate breakups become another major trend Alongside acquisitions, bankers highlighted record levels of corporate separation activity as companies simplify their structures and sharpen strategic focus. Recent examples include Comcast’s (NASDAQ:CMCSA) planned spin-off of NBCUniversal, Honeywell’s (NASDAQ:HON) proposed three-way split and the sale of Unilever Foods to McCormick & Co (NYSE:MCK). “The market is struggling more than ever to embrace businesses that are inordinately diversified,” said Akeel Sachak, global head of consumer at Rothschild & Co. “There was an era where diversity was applauded as a way of mitigating risk, but nowadays investors are more cautious because it creates undue complexity and a lack of focus from management.” Technology continues to lead global dealmaking Strong financing conditions continued to support acquisitions throughout the first half of the year. Global investment-grade corporate debt issuance reached $3.4 trillion, up 10% from a year earlier and the highest year-to-date total on record, according to LSEG. Technology remained the largest sector for mergers and acquisitions, accounting for $649 billion in announced transactions during the first six months of 2026. “AI or AI adjacent industries are one half of the equation, particularly in the U.S. The other half is the HALO side, heavy assets, low obsolescence, big infrastructure and big industry that will continue no matter what impact AI has,” said Sam Newhouse, global vice chair of Latham & Watkins’ M&A and Private Equity Practice. Cross-border acquisitions gather momentum International dealmaking also accelerated significantly during the first half of the year. Cross-border M&A reached $893 billion, a 62% increase compared with the same period in 2025 and the strongest start to a year since 2018. The United States remained the most popular destination for overseas buyers, accounting for one-quarter of all cross-border transactions, with the United Kingdom ranking second. “There are a lot more UK corporates looking outward as well rather than just the UK being taken out,” said Kirshlen Moodley, head of UK M&A for BNP Paribas. NextEra Energy stock price Dominion Energy stock price SpaceX stock price Comcast Corporation stock price Honeywell stock price McCormick stock price The post Mega-deals propel global M&A to record first half as companies pursue transformative acquisitions appeared first on US Editors. Original: Mega-deals propel global M&A to record first half as companies pursue transformative acquisitions

McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth TargetsMay 7, 2026 4:10 PM
Business Wire McKesson Corporation (NYSE: MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 7, at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company’s earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at investor.mckesson.com/events-and-presentations. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights. We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events. View source version on businesswire.com: https://www.businesswire.com/news/home/20260507625148/en/ Investors
Investors@McKesson.com Media Relations
MediaRelations@McKesson.com Original: McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming ConferencesMarch 6, 2026 8:00 AM
Business Wire
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2026 financial results after market close on Thursday, May 7, 2026. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.


Mr. Vitalone will be participating in Leerink Partners Global Healthcare Conference and Barclays Global Healthcare Conference on Wednesday, March 11, 2026. Mr. Vitalone will also participate in the BofA Securities 2026 Healthcare Conference in May 2026.


McKesson Corporation has reaffirmed fiscal 2026 full year outlook as previously issued on February 4, 2026.


The live webcast for each event will be available on McKesson’s Investor Relations website.


About McKesson Corporation


McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.


We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260305083037/en/
Investors

Investors@McKesson.com


Original: McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences

McKesson Announces Planned CFO TransitionMarch 5, 2026 8:10 AM
Business Wire
Britt Vitalone announces retirement, Kenny Cheung named as successor


McKesson Corporation (NYSE: MCK) today announced Britt Vitalone, Executive Vice President and Chief Financial Officer (CFO), has elected to retire after a successful and distinguished 20-year career with the company, including more than eight years as CFO. Looking ahead, Kenny Cheung will join McKesson as Executive Vice President and CFO, effective May 29, 2026.


“Britt is an exceptional partner and leader. He has been instrumental in advancing the company’s financial performance, engaging with shareholders, and instilling a culture of financial discipline,” said Brian Tyler, Chief Executive Officer, McKesson Corporation. “He has consistently emphasized aligning strategy with execution. His financial stewardship and disciplined approach to capital allocation have driven meaningful value creation and helped strengthen our financial foundation and evolve our portfolio to position McKesson for long-term success. I’m deeply grateful for his leadership and the impact it has had on the company.”


Vitalone’s care and commitment to McKesson continues. While he will retire as the CFO, he will continue his work with McKesson, thereafter, as a strategic advisor to support a smooth transition and the planned separation of McKesson’s Medical Surgical Solutions.


The Path Forward


Cheung joins McKesson from Sysco, where he served as Executive Vice President and Chief Financial Officer, overseeing global financial planning and analysis, accounting, audit, tax, and corporate finance.


The leadership transition comes as McKesson continues to execute its strategy and deliver strong performance. In its third quarter earnings announcement, the company delivered another strong quarter, reporting record revenue and adjusted operating profit, reflecting continued momentum across its oncology and multispecialty and biopharma services platforms, along with strength in the core distribution businesses.


Cautionary Statements


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by their use of terminology such as “believes,” “expects,” “anticipates,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “projects,” “plans,” “estimates,” “targets,” or the negative of these words or other comparable terminology. Any discussion of leadership transitions, the company’s intent to separate its Medical Surgical Solutions segment into an independent company, other anticipated or completed transactions, financial outlook, guidance, trends, strategy, plans, assumptions, expectations, commitments, and intentions may also include forward-looking statements. Readers should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, McKesson undertakes no obligation to update or revise any forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, we encourage investors to read the risk factors described in McKesson’s publicly available filings with the Securities and Exchange Commission and news releases.


These risk factors include, but are not limited to: we experience costly and disruptive legal disputes and settlements, including regarding our role in distributing controlled substances such as opioids; we experience losses not covered by insurance or indemnification; we are subject to frequently changing, extensive, complex, and challenging healthcare and other laws and policies; we from time to time record significant charges from impairment to goodwill, intangibles, and other long-lived assets; we experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches; we experience significant problems with information systems or networks; we may be unsuccessful in achieving our strategic growth objectives; we may be unsuccessful in our efforts to implement initiatives to reduce or optimize our costs; we might be unable to successfully complete or integrate acquisitions or other strategic transactions, especially in the timeframes noted; we may not receive anticipated benefits from acquisitions or other strategic transactions; we might be adversely impacted by delays or other difficulties with divestitures; we are impacted by customer purchase reductions, contract non-renewals, payment defaults, and bankruptcies; our contracts with government entities involve funding, payment and compliance risks; we might be harmed by changes in our relationships or contracts with suppliers; our use of third-party data is subject to risks and limitations that could impede the growth of our data services business; we might be unable to successfully recruit and retain qualified employees; we might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models; we might be adversely impacted by competition and industry consolidation; we are adversely impacted by changes or disruptions in product supply and have difficulties in sourcing or selling products due to a variety of causes; we are adversely impacted as a result of our distribution of generic pharmaceuticals; we are adversely impacted by changes in the economic environments in which we operate; changes affecting capital and credit markets might impede access to credit, increase borrowing costs, and disrupt banking services for us and our customers and suppliers; we might be adversely impacted by changes in tax legislation or challenges to our tax positions; we might be adversely impacted by conditions and events outside of our control, such as widespread public health issues, natural disasters, and geopolitical factors; we may be adversely affected by global climate change or by regulatory or market responses to such change; and evolving expectations and regulatory requirements related to governance and sustainability matters may have an adverse effect on our business, financial condition, and results of operations and damage our reputation.


About McKesson Corporation


McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260304153396/en/
Investors

Investors@McKesson.com


Media Relations

MediaRelations@McKesson.com


Original: McKesson Announces Planned CFO Transition

McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS GuidanceFebruary 4, 2026 4:10 PM
Business Wire
McKesson Corporation (NYSE: MCK) has released its fiscal 2026 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.


As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 4 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company’s earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at investor.mckesson.com/events-and-presentations.


About McKesson Corporation


McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.


We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260204803103/en/
Investors

Investors@McKesson.com


Media Relations

MediaRelations@McKesson.com


Original: McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance

MCK new 52 week high

Nice Chart!!

MCK new 52=week high

MCK new 52 week high

$MCK short squeeze signal Mckesson Corporation Nyse Mck Short Squeeze

148.55

What the?

Love the jump today!

Should I sell? Thoughts

Will it go higher?

MCK buy option 155.10

buy 16 JUN 17 155 call for 3.60









normal chart




log chart

Where's this going?

What the

McKesson Corp $MCK valuation models show nice upside before earnings Wednesday...

Fair Value Analysis

Took a position here today

McKesson (MCK +0.78%) was downgraded to 'Neutral' from 'Overweight' at JPMorgan Chase with an 18-month target price of $169.

Help!!!!!

Help!!!!!

Stop the bleeding

CEO just sold 200k shares wowza that is generally not a good sign in that kind of size/amount!

http://sports.yahoo.com/news/mckesson-corp-mck-chairman-president-001501238.html

Downgraded? I'd watch out for the $162 open tomorrow if holding.

What's going on?????????

$150-$160 Coming ouch.

I think I can I think I can I think I can

Help!!!!

Good short candidate but beware the risk very volatile with target price $139 http://charts.stocktwits.com/production/stream_52106368.?1459490130

What's happening?

Will you ever get close to $200 again?

Come on baby! Break the $200 mark again.

McKesson partner RXSF @ .0053 looking to Uplist to NASDAQ could be worth an investment there.

McKesson to $300 ? What is to stop steady rise to $300 per share ? Solid business, solid company, rising Obamacare demand !!

The play on Obamacasre !!

$MCK DD Notes ~ http://www.ddnotesmaker.com/MCK

bullish very long term

$MCK recent news/filings

## source: finance.yahoo.com

Tue, 28 Oct 2014 11:07:07 GMT ~ Q2 2015 McKesson Corp Earnings Release - After Market Close


read full: http://biz.yahoo.com/research/earncal/20141028.html?t=mck
*********************************************************

Mon, 27 Oct 2014 18:03:08 GMT ~ Payers and Providers Unite at McKesson Health Solutions Conference 2014

[at noodls] - October 27, 2014 New McKesson Health Solutions president Rod O'Reilly joins other industry experts to discuss healthcare's transition from volume to value NEWTON, Mass., October 27, 2014 - Today McKesson ...

read full: http://www.noodls.com/view/8F58531EB023750E1A0B96BAE6BC54F483775703
*********************************************************

Mon, 27 Oct 2014 18:03:08 GMT ~ McKesson and HSE Wins IMSTA Med Tech 2014 Awards

[at noodls] - October 15, 2014 NIMIS recognised for Best Improvement in Patient Safety MANCHESTER, 15, October, 2014 - McKesson Imaging & Workflow Solutions and the Health Service Executive have been announced as the ...

read full: http://www.noodls.com/view/BD2AF2D7928476FA0F9CD2CE173FBB9D999E5208
*********************************************************

Mon, 27 Oct 2014 18:03:08 GMT ~ McKesson Declares Quarterly Dividend October 21, 2014

[at noodls] - October 21, 2014 SAN FRANCISCO - October 21, 2014 - The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of twenty-four cents per share on Common Stock. The dividend ...

read full: http://www.noodls.com/view/B83274E3E67F84C71A07F4A4AF33D31EA5149836
*********************************************************

Thu, 23 Oct 2014 20:01:00 GMT ~ AmerisourceBergen's Move To Go Big Is The Right Rx


read full: http://news.investors.com/102314-723188-amerisourcebergen-walgreen-express-scripts-deals-drive-growth.htm?ven=yahoocp&src=aurlled&ven=yahoo
*********************************************************


$MCK charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$MCK company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/MCK/company-info
Ticker: $MCK
OTC Market Place: Not Available
CIK code: 0000927653
Company name: McKesson Corp.
Company website: http://www.mckesson.com
Incorporated In: DE, USA


$MCK share structure

## source: otcmarkets.com

Market Value: $46,945,161,489 a/o Oct 27, 2014
Shares Outstanding: 231,599,218 a/o Jun 30, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$MCK extra dd links

Company name: McKesson Corp.
Company website: http://www.mckesson.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/MCK/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/MCK/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=MCK+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=MCK+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=MCK+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/MCK/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/MCK/news - http://finance.yahoo.com/q/h?s=MCK+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/MCK/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/MCK/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/MCK/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/MCK/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/MCK/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/MCK/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/MCK/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/MCK/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=MCK+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/MCK
DTCC (dtcc.com): http://search2.dtcc.com/?q=McKesson+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=McKesson+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=McKesson+Corp.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.mckesson.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.mckesson.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.mckesson.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/MCK/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/MCK
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/MCK/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/MCK/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/MCK/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000927653&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/MCK/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/MCK/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/MCK/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/MCK/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=MCK&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=MCK
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/MCK/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=MCK+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=MCK+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=MCK
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=MCK
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=MCK+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/MCK/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=MCK+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/MCK.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=MCK
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/MCK/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/MCK/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/MCK/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/MCK/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/MCK
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/MCK
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/MCK:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=MCK
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MCK



$MCK DD Notes ~ http://www.ddnotesmaker.com/MCK

Boom! Were there.

Under a dime away from $200.00

Under $2.00 to hit the &200.00 mark

Knocking on the door $200.00

Come'on baby you can hit $200

Dont own many stocks over $100 let alone $50,but this is one for the long haul.Obamacare will propel this one upwards and upwards over time.

Think she will break $200

Think she'll break 100

MCK signs agreement with RMCP!!!

Revolutions Medical Signs Distribution Agreement With McKesson
Date : 11/16/2012 @ 1:32PM
Source : MarketWire
Stock : Revolutions Medical Corp. (QB) (RMCP)
Quote : 0.095 0.015 (18.75%) @ 4:35PM

Revolutions Medical Signs Distribution Agreement With McKesson
Print
Alert
Revolutions Medical Corp. (QB) (USOTC:RMCP)
Intraday Stock Chart
Today : Saturday 17 November 2012


Revolutions Medical Corporation (OTCQB: RMCP) announced today that the Company has entered into a vendor and distribution agreement with McKesson Corporation ("McKesson") for the distribution of the Company's RevVac™ auto-retractable vacuum safety syringe in the United States healthcare market. McKesson is one of the leading medical-surgical supply and distribution companies in the United States, while also serving as one of the country's largest pharmaceutical distributors, supplying more than 40,000 pharmacy locations across the U.S. Pursuant to the terms of the vendor and distribution agreement, the RevVac™ auto-retractable vacuum safety syringe is now available to over 550 McKesson sales representatives through their distribution network and order processing system.
Ron Wheet, the Company's Chief Executive Officer and Chairman, stated, "Since introducing the RevVac™ safety syringe to the U.S. health care market in the second quarter 2012, the Company has considered several available options to best manage the roll out of our product. We are very pleased to have the RevVac™ safety syringe distributed by McKesson, one of the best names in health care quality in the world. We believe this relationship will complement our additional sales efforts with MedPro Associates."

About Revolutions Medical Corporation

Revolutions Medical Corporation is a safety medical device and software application company. Its proprietary technologies and products include: the RevVac™ safety syringe, safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS) and prefilled vacuum auto-retraction safety syringes.

For additional information, please visit Revolutions Medical corporate website:

http://www.revolutionsmedical.com/

To be added to the Revolutions Medical investor email list, please email:

investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

CONTACT:



Revolutions Medical Corporation

Investor Relations

Tel.: (843) 606-9461

Hey Mac http://investorshub.advfn.com/boards/read_msg.aspx?message_id=73496842

~ $MCK ~Multi chart fix and On the house shots of DD!! Version 3.2.3







~ Barchart: http://barchart.com/quotes/stocks/MCK?
~ OTC Markets: http://www.otcmarkets.com/stock/MCK/company-info
~ Google Finance: http://www.google.com/finance?q=MCK
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=MCK#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=MCK+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=MCK
Finviz: http://finviz.com/quote.ashx?t=MCK
~ BusyStock: http://busystock.com/i.php?s=MCK&v=2
~ CandlestickChart: http://www.candlestickchart.com/cgi/chart.cgi?symbol=MCK&exchange=US
~ Investorshub Trades: http://ih.advfn.com/p.php?pid=trades&symbol=MCK
~ Investorshub Board Search: http://investorshub.advfn.com/boards/getboards.aspx?searchstr=MCK
~ Investorshub PostStream Search: http://investorshub.advfn.com/boards/poststream.aspx?ticker=MCK
~ Investorshub Goodies Search: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=23302&srchyr=2011&SearchStr=MCK
~ Investorshub Message Search: http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=MCK
~ MarketWatch: http://www.marketwatch.com/investing/stock/MCK/profile
~ E-Zone Chart: http://www.windchart.com/ezone/signals/?symbol=MCK
~ 5-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK
~ 10-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK&size=l&frequency=10&color=g
~ 30-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK&size=l&frequency=30&color=g
~ 60-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK&size=l&frequency=60&color=g

DTCC (PENSON/TDA) Check - (otc and pinks) - Note ~ I did not check for this chart blast. However, I try and help you to do so with the following links.
IHUB DTCC BOARD SEARCH #1 http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=MCK
IHUB DTCC BOARD SEARCH #2: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=14482&srchyr=2011&SearchStr=MCK
Check those searches for recent MCK mentions. If MCK is showing up on older posts and not on new posts found in link below, The DTCC issues may have been addressed and fixed. Always call the broker if your security turns up on any DTCC/PENSON list.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=Complete+list
For a cMCKnt list see the pinned threads at the top here ---> http://tinyurl.com/TWO-OLD-FARTS


Volume, MACD, ADX 3 EMA Par sar - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=8&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=2&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=16&lf=1&lf2=4&lf3=1024&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=25&y=5
RSI, Money Flow, Volume Accumulation, 3sma, Bollinger bands - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=8&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=2&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=4&maval=9&uf=8&lf=2&lf2=512&lf3=4096&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=36&y=14
Price Channel, Momentum, Volatility Slow, P/E Ratio - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=8&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=2&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=128&lf=65536&lf2=16384&lf3=16777216&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=28&y=15



Volume, MACD, ADX 3 EMA Par sar - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=6&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=16&lf=1&lf2=4&lf3=1024&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=39&y=17
RSI, Money Flow, Volume Accumulation, 3sma, Bollinger bands - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=6&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=4&maval=9&uf=8&lf=2&lf2=512&lf3=4096&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=35&y=12
Price Channel, Momentum, Volatility Slow, P/E Ratio - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=6&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=128&lf=65536&lf2=16384&lf3=16777216&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=23&y=19



Volume, MACD, ADX 3 EMA Par sar - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=18&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=8&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=16&lf=1&lf2=4&lf3=1024&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=38&y=6
RSI, Money Flow, Volume Accumulation, 3sma, Bollinger bands - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=18&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=8&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=4&maval=9&uf=8&lf=2&lf2=512&lf3=4096&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=30&y=11
Price Channel, Momentum, Volatility Slow, P/E Ratio - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=&symb=MCK&time=18&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=8&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=128&lf=65536&lf2=16384&lf3=16777216&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=35&y=14



Volume, MACD, ADX 3 EMA Par sar - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=3&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=7&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=16&lf=1&lf2=4&lf3=1024&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=39&y=14
RSI, Money Flow, Volume Accumulation, 3sma, Bollinger bands - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=3&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=7&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=4&maval=9&uf=8&lf=2&lf2=512&lf3=4096&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=20&y=16
Price Channel, Momentum, Volatility Slow, P/E Ratio - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=3&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=7&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=128&lf=65536&lf2=16384&lf3=16777216&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=46&y=6



Volume, MACD, ADX 3 EMA Par sar - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=1&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=6&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=16&lf=1&lf2=4&lf3=1024&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=42&y=20
RSI, Money Flow, Volume Accumulation, 3sma, Bollinger bands - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=1&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=6&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=4&maval=9&uf=8&lf=2&lf2=512&lf3=4096&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=36&y=11
Price Channel, Momentum, Volatility Slow, P/E Ratio - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=1&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=6&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=128&lf=65536&lf2=16384&lf3=16777216&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=46&y=11



Volume, MACD, ADX 3 EMA Par sar - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=1&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=9&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=16&lf=1&lf2=4&lf3=1024&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=31&y=14
RSI, Money Flow, Volume Accumulation, 3sma, Bollinger bands - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=1&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=9&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=4&maval=9&uf=8&lf=2&lf2=512&lf3=4096&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=23&y=15
Price Channel, Momentum, Volatility Slow, P/E Ratio - http://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=True&insttype=Stock&symb=MCK&time=1&startdate=1%2F4%2F1999&enddate=11%2F21%2F2011&freq=9&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=6&maval=9&uf=128&lf=65536&lf2=16384&lf3=16777216&type=4&style=380&size=2&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=22&y=15



























---------------------













---------------------
























* If a symbol changes or adds a D, etc. Message me for an updated version.
Twitter: @MACDgyver ---> MCK <---

~ $MCK ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $MCK ~ Earnings expected on Monday *
This Week In Earnings: Earnings are coming or are already posted! This is what the charts look like! If you play the earnings these posts can be very helpful to you!
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=MCK&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=MCK&p=W&b=3&g=0&id=p54550695994



~ Barchart: http://barchart.com/quotes/stocks/MCK?
~ OTC Markets: http://www.otcmarkets.com/stock/MCK/company-info
~ Google Finance: http://www.google.com/finance?q=MCK
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=MCK#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=MCK+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=MCK
Finviz: http://finviz.com/quote.ashx?t=MCK
~ BusyStock: http://busystock.com/i.php?s=MCK&v=2
~ CandlestickChart: http://www.candlestickchart.com/cgi/chart.cgi?symbol=MCK&exchange=US
~ Investorshub Trades: http://ih.advfn.com/p.php?pid=trades&symbol=MCK
~ Investorshub Board Search: http://investorshub.advfn.com/boards/getboards.aspx?searchstr=MCK
~ Investorshub PostStream Search: http://investorshub.advfn.com/boards/poststream.aspx?ticker=MCK
~ Investorshub Goodies Search: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18582&srchyr=2011&SearchStr=MCK
~ Investorshub Message Search: http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=MCK
~ MarketWatch: http://www.marketwatch.com/investing/stock/MCK/profile
~ E-Zone Chart: http://www.windchart.com/ezone/signals/?symbol=MCK
~ 5-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK
~ 10-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK&size=l&frequency=10&color=g
~ 30-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK&size=l&frequency=30&color=g
~ 60-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MCK&size=l&frequency=60&color=g


http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.